Boston Family Office LLC cuts holdings in Abbott Laboratories

Boston Family Office LLC reduced its holdings in Abbott Laboratories by 3.9 percent during the fourth quarter. The firm owned 107,039 shares of the healthcare product maker’s stock after selling 4323 shares during the quarter. Boston Family Office LLC’s holdings in Abbott Laboratories were worth USD 7,742,000 at the end of the most recent reporting period. The company is satisfied with the performance of its equal joint venture (JV) with Zydus Cadila. The JV is called Bayer Zydus Pharma.